Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C22H25ClN2O5 |
| Molecular Weight | 432.897 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COCCCOC1=C(Cl)N=C2C(=C1)[C@H]3CCC(C)(C)[C@H]3N4C=C(C(O)=O)C(=O)C=C24
InChI
InChIKey=JFVCUINASNRMTO-BLVKFPJESA-N
InChI=1S/C22H25ClN2O5/c1-22(2)6-5-12-13-9-17(30-8-4-7-29-3)20(23)24-18(13)15-10-16(26)14(21(27)28)11-25(15)19(12)22/h9-12,19H,4-8H2,1-3H3,(H,27,28)/t12-,19+/m1/s1
| Molecular Formula | C22H25ClN2O5 |
| Molecular Weight | 432.897 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 19:16:51 GMT 2025
by
admin
on
Wed Apr 02 19:16:51 GMT 2025
|
| Record UNII |
NZZ7UWE8JN
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
138523931
Created by
admin on Wed Apr 02 19:16:51 GMT 2025 , Edited by admin on Wed Apr 02 19:16:51 GMT 2025
|
PRIMARY | |||
|
2305766-58-7
Created by
admin on Wed Apr 02 19:16:51 GMT 2025 , Edited by admin on Wed Apr 02 19:16:51 GMT 2025
|
PRIMARY | |||
|
300000054252
Created by
admin on Wed Apr 02 19:16:51 GMT 2025 , Edited by admin on Wed Apr 02 19:16:51 GMT 2025
|
PRIMARY | |||
|
NZZ7UWE8JN
Created by
admin on Wed Apr 02 19:16:51 GMT 2025 , Edited by admin on Wed Apr 02 19:16:51 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET ORGANISM->INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Acts as an RNA destabilizer by inhibiting PAPD5/7 to degrade HBV RNA.
|